EphA4

EphA4

EphA4 Molekülinformation

Molecule Name
Erythropoietin-producing hepatocellular receptor A4
Molekülalias
EphA4,HEK8,SEK,TYRO1,EK8
Drug Development Progress
Anzahl der klinischen Arzneimittel3
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Target-Alias
Ephrin type-A receptor 4,EPH-like kinase 8 (EK8; hEK8),Tyrosine-protein kinase TYRO1,Tyrosine-protein kinase receptor SEK,EPH Receptor A4,TYRO1,HEK8,Tyrosine-Protein Kinase Receptor SEK,Tyrosine-Protein Kinase TYRO1,Ephrin Type-A Receptor 4,EPH-Like Kinase 8,EC 2.7.10.1,EK8,SEK,Receptor Protein-Tyrosine Kinase HEK8,TYRO1 Protein Tyrosine Kinase,EC 2.7.10
Molekülhintergrund
Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.

EphA4 Produktliste

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
EphA4
Human EphA4 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISA

$310.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
ORT-247ORT247; ORT-247Phase 1 ClinicalOrthogonal Neuroscience Inc
Amyotrophic Lateral Sclerosis
Details
mEphA4-FcmEphA4-FcPhase 1 ClinicalQueensland Brain Institute
Amyotrophic Lateral Sclerosis; Nerve Degeneration; Nervous System Diseases
Details
E2025E-2025; E2025Phase 1 ClinicalEisai Inc
Alzheimer Disease
Details
Customer Reviews